ETHIONAMIDE

Ethionamide is a second-line antitubercular drug inhibiting mycolic acid synthesis in Mycobacterium tuberculosis. Side effects include hepatotoxicity, GI upset, and neurological symptoms such as peripheral neuropathy.

SKU: cb3694b3f6cd Category: Tag:

Product Description


Mechanism of Action

Ethionamide is a prodrug activated by mycobacterial monooxygenase (EtaA). The activated form inhibits InhA, an enoyl‑ACP reductase required for mycolic‑acid synthesis, thereby disrupting the integrity of the mycobacterial cell wall.

Benefits and Advantages

Used in TB‑pathway research, prodrug‑activation assays, mycolic‑acid biosynthesis studies, and multidrug‑resistance modelling.

Side Effects and Risks

Risks include hepatotoxicity, GI intolerance, neurotoxicity and hypothyroidism. Handle with antimycobacterial‑thioamide precautions.

Datasheet


Molecular Formula

C8H10N2S

Molecular Weight

166.25 g/mol

CAS Number

536-33-4

Storage Condition

Ethionamide film-coated tablets should be stored in tight containers at 20-25 °C.

Solubility

less than 1 mg/mL at 70 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

ethionamide; 536-33-4; 2-ethylpyridine-4-carbothioamide; Trecator; Ethioniamide

IUPAC/Chemical Name

2-ethylpyridine-4-carbothioamide

InChl Key

AEOCXXJPGCBFJA-UHFFFAOYSA-N

InChl Code

InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)

References

https://pubchem.ncbi.nlm.nih.gov/compound/2761171;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download